How genetic differences in memory T cells may drive IBD across ancestries

Trans-ancestry, single-cell multiomics dissection of IBD-associated loci in CD4 memory T cells

NIH-funded research University of Pittsburgh at Pittsburgh · NIH-11290360

This project looks at how inherited genetic differences change immune memory T cells in people with Crohn’s disease or ulcerative colitis, including across diverse ancestry groups.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-11290360 on NIH RePORTER

What this research studies

From a patient's perspective, researchers will examine individual immune cells (CD4 memory T cells) from people with IBD using single-cell multiomics to read gene activity and regulatory marks. They will combine genetic information from people of different ancestries with epigenetic and gene-expression data to pinpoint which non-coding DNA changes alter T cell behavior. The team focuses on important IBD-linked regions like the PTGER4 area and how signals such as PGE2, IL-1β, and IL-23 change immune responses. By linking specific genetic variants to cell functions, the work aims to explain ancestry-related differences in IBD risk and suggest new therapeutic directions.

Who could benefit from this research

Good fit: Ideal candidates would include adults with Crohn’s disease or ulcerative colitis (and possibly matched controls) who can provide blood and/or tissue samples and represent diverse ancestral backgrounds.

Not a fit: People seeking immediate new treatments or those without IBD are unlikely to gain direct or immediate clinical benefit from this research.

Why it matters

Potential benefit: If successful, this could reveal biological targets and pathways that lead to more precise treatments and better understanding of why IBD risk differs by ancestry.

How similar studies have performed: Previous genetic and bulk-tissue studies have identified many IBD risk regions and some links to immune function, but single-cell multiomic, trans-ancestry mapping of CD4 memory T cells is a newer approach with limited prior clinical translation.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.